S3ma is a synthetic GLP-1 receptor agonist research peptide. It is supplied for in-vitro investigation of incretin receptor signalling, and is not for human or veterinary use.
Mechanistic focus
- Investigated in GLP-1 receptor signalling pathways
- Explored in studies involving metabolic and endocrine system interaction
- Studied for its role in glucose regulation signalling models
Research applications
- Metabolic pathway research
- Endocrine signalling systems
- Receptor-mediated peptide interaction
Handling & specification
Supplied as a lyophilised powder in a sealed vial, strength as labelled. Store lyophilised material cold and away from light; once reconstituted with bacteriostatic water, keep refrigerated and protected from light. Reconstitution volume is determined by the researcher according to the experimental protocol.
Purity & documentation
Every batch is supplied with batch-specific Certificate of Analysis (COA) documentation where applicable, accessible via the QR code on the vial label or through our COA Verification page. Use the product name and batch/lot number on the vial to locate the relevant records.
Despatched from the UK with tracked delivery.
For research purposes only. Not for human or veterinary use. Sold to qualified researchers and institutions for in-vitro laboratory research only.
